Invitrogen™ Human LGI1 Synthetic Peptide

Ref.: BL-RE-176116Manufacturer ref.: PEP-0611 50 μg
€149.00 excl. VAT

LGI1 Synthetic Peptide, PEP-0611, from Invitrogen.

Gene ID (Enter)
9211
Species
Human
Purification method
Purified
Accession number
O95970
Common name
Human LGI1
Brand
Invitrogen

LGI1 Synthetic Peptide, PEP-0611, from Invitrogen.

LGI1 Synthetic Peptide, PEP-0611, from Invitrogen.

The leucine-rich, glioma inactivated gene 1 (LGI1) was first identified as a candidate tumor suppressor gene for glioma and may play a role in other cancers. LGI1 is a member of a family of highly related proteins containing leucine-rich repeats (LRRs) which are highly similar to other transmembrane signaling molecules and receptors. LGI1 serves as a ligand to ADAM22, a metalloprotease localized at the synapse. Mutations in LGI1 account for nearly half of autodominant lateral temporal epilepsy (ADTLE), an epileptic syndrome characterized by focal seizures with predominant auditory symptoms. Two isoforms of LGI1 are known to exist.

Species

Species: Human.

Conservation

Storage: -20°C.

Formulation

Concentration: 200 μg/mL.

Regulatory status

Research only (RUO).

Packaging

Packaging: 50 μg.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15338770
Specifications
Gene ID (Enter)9211
SpeciesHuman
Purification methodPurified
Accession numberO95970
Common nameHuman LGI1
Concentration200 μg/mL
DescriptionSynthetic Peptide
FormatLiquid
FormulaPBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
For use with (application)Blocking Assay, Control
Gene symbol(s)LGI1
LyophilizedNo
Product typePeptide
Quantity50 μg
Regulatory statusRUO - research use only
Storage and shipping
Content and storage-20°C
Conservative0.02% sodium azide
Storage stampPBS

Origin and customs

Manufacturer ref.PEP-0611
Country of originUnited States
HS customs code3824 99 92 00
A question or a specific configuration?
Contact us for a quote.